[EATG Global HIV News daily digest] Digest #194-2009

[EATG Global HIV News daily digest]

Global HIV News Daily Digest

Copied as fair use  -  Ana  -






  




Latest Headlines




  Harvard, Yale, three schools back drug policies to help poor 
  Access to treatment Monday 09 November 2009
					
  
Harvard University, Yale University, Brown University, the University
of Pennsylvania and Boston University are pledging to encourage
companies to give poor countries better access to drugs and medical
products based on discoveries made on their campuses. 
  SOURCE:
Bloomberg.com




  EU tramples on India's poor
  EU Policy Monday 09 November 2009
					
  
The EU is pushing an unsavoury free trade deal that would force India
to give up control of its banking sector and drugs industry.
  SOURCE:
Gaurdian.uk




  Concert Pharmaceuticals initiates Phase 1b clinical trial of CTP-518, protease inhibitor for treatment of HIV
  Treatment Monday 09 November 2009
					
  
Concert earns $12 million milestone from GlaxoSmithKline; CTP-518 has potential as unboosted HIV protease inhibitor.
  SOURCE:
Concert Pharmaceuticals, Inc.




  WHO report on the health of women: AIDS leading cause of death globally in women of reproductive age
  Epidemiology Monday 09 November 2009
					
  
AIDS-related illness is the leading cause of death and disease among
women of reproductive age in low and middle income countries,
particularly in Africa.
  SOURCE:
UNAIDS




  Vitamin D has benefits in chronic HCV infection
  Hepatitis Monday 09 November 2009
					
  
"This preliminary study confirms the benefit of adding vitamin D to
conventional antiviral therapy in patients with chronic HCV."
  SOURCE:
Medscape Today




  Newer fluoroquinolones may improve outcome in extensively drug-resistant TB
  Tuberculosis & Malaria Monday 09 November 2009
					
  
"For public health institutions that care for patients with this
disease, a later-generation fluoroquinolone should be included as a
treatment option for XDR-TB, regardless of sensitivity results from the
patient's cultures." 
  SOURCE:
Medscape  Today


----------------------------------------------------
DISCLAIMER
The articles in this digest represent a diversity of opinions on topics
of interest to the HIV treatment activist community. The EATG is not
responsible for their content. The articles posted in this digest do
not necessarily reflect EATG views or opinions.
FAIR USE NOTICE
The digest may contain copyrighted material which has not always been
specifically authorised by the copyright owner. Such material is made
available for educational purposes to advance the understanding of
scientific, ethical, legal and social issues. It is believed that this
constitutes a 'fair use' of any such copyrighted material. This
material is distributed without profit.


 

Information in this digest was accurately quoted during its compilation.



__________________________________________________
Do You Yahoo!?
Tired of spam?  Yahoo! Mail has the best spam protection around 
http://mail.yahoo.com 
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.eatg.org/pipermail/eatg-forum_eatg.org/attachments/20091109/84b4634d/attachment.html>